General Information |
|
| NSE Symbol* | SEQUENT |
| Name of the Company* | SEQUENT SCIENTIFIC LIMITED |
| ISIN* | INE807F01027 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2026-02-05 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2026-01-01 |
| Details of Trading Window Closure End date | 2026-02-07 |
| Short Notice | |
| Date of Report* | 2026-01-21 |
Agenda Details |
|
| Agenda* |
1) Financial results |
| Whether results are audited or unaudited | Unaudited |
| Nature of report standalone or consolidated | Standalone And Consolidated |
| Period end Type | Quarterly |
| Period up to (Month) | December |
| Period up to (Year) | 2025 |
| Mode of raising Funds | |
| Type of Dividend | |
| Remarks (website dissemination) | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025. |